Shuji Ogino, MD, PhD, Dana-Farber, Brigham and Women's Hospital (IMAGE)
Caption
In a study by researchers at Dana-Farber Cancer Institute, aspirin therapy can extend the life of colorectal cancer patients whose tumors carry a mutation in a key gene.
Credit
Dana-Farber Cancer Institute
Usage Restrictions
None
License
Licensed content